Table.
Virological assessment results for SARS-CoV-2 at baseline and day 8 after the event
Control group (n=495) | Experimental group (n=465) | |
---|---|---|
Baseline screening | ||
Ag-RDT positive | 0 | 0 |
TMA positive* | 15 (3·0%) | 13 (3%) |
Cell culture positive | 0 | 0 |
RT-PCR positive | 1 (<1%) | 1 (<1%) |
Ct value | 37 | 37 |
Follow-up assessment | ||
Ag-RDT positive | 2 (0·4%) | 0 |
TMA positive† | 15 (3·0%) | 12 (3%) |
TMA positive at baseline | 4 | 3 |
TMA negative at baseline | 11 | 9 |
RT-PCR positive | 2 (0·4%) | 0 |
Ct value | 26·3; 28·3 | NA |
Infected with SARS-CoV-2 | 2 (0·4%) | 0 |
Ag-RDT=antigen-detecting rapid diagnostic tests. TMA=transcription-mediated amplification test. RT-PCR=real-time reverse transcriptase-polymerase chain reaction. Ct=cycle threshold. NA=not applicable.
Three TMA results in the control group were inconclusive.
One TMA result in the experimental group was inconclusive.